OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. Various strategies have been employed enhance antibody titer, including process parameter optimization, genetic engineering, and implementation of perfusion processes. Fine-tuning culture conditions